Patients die in Global Blood Therapeutics study By: MarketMinute.com Stock News December 12, 2017 at 18:09 PM EST Two of seven patients in Global Blood Therapeutics Inc. (Nasdaq: GBT) study of voxelotor died. The stock price plummeted $6.38 to close at $38.40. Related Stocks: Global Blood Ther